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the surface tension to near zero values and thus preventing the lungs from collapse. Due to the expanding field of nanotech-
nology and the corresponding unavoidable exposure of human beings from the air, it is crucial to study the potential effects
of nanoparticles (NPs) on the structural organization of the lung surfactant system. In the present study, we investigated
both, the domain structure in pure DPPC monolayers as well as in lung surfactant model systems. In the pure lipid system
we found that two different sized hydrophobic polymeric nanoparticles with diameter of ~12 nm and ~136 nm have contrasting
effect on the functional and structural behavior. The small nanoparticles inserted into fluid domains at the LE-LC phase transition
are not visibly disturbing the phase transition but disrupting the domain morphology of the LE phase. The large nanoparticles led
to an expanded isotherm and to a significant decrease in the line tension and thus to a drastic disruption of the domain structures
at a much lower number of nanoparticles with respect to the lipid. The surface activity of the model LS films again showed drastic
variations due to presence of different sized NPs illustrated by the film balance isotherms and the atomic force microscopy. AFM
revealed laterally profuse multilayer protrusion formation on compression but only in the presence of 136 nm sized nanopar-
ticles. Moreover we investigated the vesicle insertion process into a preformed monolayer. A severe inhibition was observed
only in the presence of ~136 nm NPs compared to minor effects in the presence of ~12 nm NPs. Our study clearly shows
that the size of the nanoparticles made of the same material determines the interaction with biological membranes.INTRODUCTIONLung surfactant (LS) is a complex lipid-protein film span-
ning the air-water interface of the alveoli in the lungs. Its
primary function is to reduce the surface tension at the
air-water interface, which thus is most essential for the
normal breathing process. During the process of inhalation,
the reduction in surface tension renders the process effort-
less and during exhalation, this property prevents the lungs
from collapse. In view of the essential functional behavior of
the lung surfactant, it is known to reduce the surface tension
to near zero values during compression and respread instan-
taneously without breaking during subsequent expansion
(1–3). The mammalian lung surfactant consists mainly of
~85–90% phospholipids and 8–10% of fatty acids, choles-
terols, and surfactant-specific proteins (4–6). The domi-
nantly present phospholipids are zwitterionic saturated
phosphatidylcholines (PC) (40–50%) primarily responsible
for decreasing the surface tension to near zero values (7).
However, it has poor respreading properties and rigidifies
the surfactant film. To enhance the respreading properties,
the second most abundant lipids present are the negatively
charged phosphatidylglycerols (PG) and unsaturated phos-Submitted May 17, 2013, and accepted for publication October 10, 2013.
*Correspondence: gallah@uni-muenster.de
Rakesh Kumar Harishchandra’s present address is Department of Chemis-
try and Biochemistry, Worcester Polytechnic Institute (WPI), 60 Prescott
Street, Worcester, MA 01605.
Editor: Klaus Gawrisch.
 2014 by the Biophysical Society
0006-3495/14/01/0289/10 $2.00pholipids that fluidize the lung surfactant film. Along with
these, surfactant-specific proteins also play a crucial role
in the normal functioning of the surfactant film. The surfac-
tant-specific proteins SP-B and SP-C are mainly involved in
enhancing the surface activity of the surfactant film during
compression and expansion (5,8). Whereas SP-A and SP-
D are related to the immunological and host defense mech-
anism (9). Over the years, a good amount of literature has
cleared our knowledge about action of the lung surfactant
film. On compression, the fluid components of the lipid-
protein monolayer squeeze out to form three-dimensional
(3D) multilayer stacks or protrusion structures, which acts
as a surfactant reservoir. On expansion, these multilayer
stacks are reincorporated into the monolayer and assist the
respreading of the film to form a stable lung surfactant
film. The presence of these structures in vivo has been evi-
denced by atomic force microscopy (AFM) and electron
microscopy (EM) studies. These multilayer stacks are
formed and held together by the aid of SP-B and SP-C
and hence the lipid and protein components of the surfactant
film interact and harmonize with each other during the
breathing cycle (10–13). The surfactant-specific proteins
SP-B and SP-C also play an important role in the recycling
and replenishment of the lipid material by the vesicle inser-
tion process (14–16).
Although advances in nanotechnology has brought to us
novel methods in medical diagnostics and targeted drughttp://dx.doi.org/10.1016/j.bpj.2013.10.036
290 Dwivedi et al.delivery, it has also made us prone to exposure of nanopar-
ticles (NPs) through inhalation from the atmosphere. It is
hence of utmost importance to study the effect of the
intentional or unintentional exposure of nanosized particles
to the lung surfactant. The important parameters to be inves-
tigated in these nanoparticle interaction studies are—distur-
bance of the structural and functional behavior of the LS
film, interaction with the individual components of the LS
film, retention/penetration of the NPs in the film, and inter-
action with epithelial cells and alveolar macrophages.
Recently, numerous amounts of research have been dedi-
cated tomonitor the toxicological influence of different kinds
of NPs on the lungs and the further fate of the NPs (17–19). A
few reports have focused on the lung surfactant dysfunction
caused by the inhalation and penetration of NPs through
the lung surfactant film. In most cases, the lung surfactant
dysfunction has been caused in a dose- and time-dependent
manner by the frequently used metallic NPs, which indeed
form a major part of the particulate matter in the atmosphere
and are also employed in medical diagnostics (20–23). How-
ever, seldom have the dosages been physiologically relevant.
It has also now become clear that the toxicological effect of
NPs are more or less dependent upon the surface properties,
shape, size, solubility, and surface charge of the NPs (24). It
has been previously shown that 20 nm AmorSil20 polymeric
hydrophobic NPs tend to inhibit the lung surfactant function
at high concentrations and a detailed study employing
various applications of AFM and EM showed that these
hydrophobic NPs are retained into the surfactant film even
after repetitive compression expansion cycles (22,25). This
behavior of a few NPs to retain into the surfactant film could
be exploited by the drug delivery applications for long-term
release of the drugs into the systembefore theNPs are cleared
out. Hence, these NPs are required to cause minimal distur-
bance to the lung surfactant function. In this report, we
have studied the effect of size of NPs on the biophysical
behavior of model LS films and proved that the size of the
NPs is an important factor responsible for causing severe
damage to the lung surfactant structure.
In view of the highly complex and dynamic nature of
the natural lung surfactant film, it is technically challenging
to extract any valuable information from such a system
and hence a well-characterized and highly reproducible
model system has been developed that closely mimics the
natural lung surfactant. It consists mainly of the zwitterionic
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), ne-
gatively charged 1,2-dipalmitoyl-sn-glycero-3-phosphogly-
cerol (DPPG) and surfactant-specific protein SP-C
(26–28). In this study, we have investigated the influence
of size of hydrophobic polymeric NPs on the lung surfactant
model system. We have studied the variation in the surface
activity of the lung surfactant model system in the presence
of small NPs (diameter ¼ 12.4 5 2.6 nm, determined by
transmission electron microscopy (TEM), particles depos-
ited from chloroform) and large NPs (diameter ¼ 136 5Biophysical Journal 106(1) 289–29827.0 nm, TEM, particles deposited from chloroform) with
the same surface characteristics as the previously studied
NPs (AmorSil20) with a diameter ~20 nm consisting of inert
Si-CH3 groups making it essentially hydrophobic in nature.
The evidently contrasting surface activity behavior of the
lung surfactant model system in the presence of different
sized NPs has been further explored using the AFM tech-
nique. The factors that are focused upon in this study
are—variation in the surface activity of the LS model
system and hence inhibition of surfactant function, the
effect of size variance on the line tension and domain
morphology, the effect of size on the 3D protrusion struc-
tures, localization of the different sized NPs around the
protrusion structures, and analysis of the multilayer steps
of the protrusion structures. Furthermore, the size-depen-
dent effect of hydrophobic NPs on the vesicle insertion pro-
cess is studied by vesicle insertion kinetic studies.MATERIALS AND METHODS
Materials
DPPC and DPPGwere purchased fromAvanti Polar Lipids (Alabaster, AL).
SP-C was isolated from porcine bronchoalveolar lavage fluid by the butanol
extraction method (29,30). 2-(4, 4-Difluoro-5-methyl-4-bora-3a, 4a-diazas-
indacene-3-dodecanoyl)-1-hexadecanoyl-sn-glycero-3-phosphocholine (b-
BODIPY 500/510 C12-HPC, BODIPY-PC) was purchased from Molecular
Probes (Eugene, OR). Chloroform and methanol were high pressure liquid
chromatography grade and obtained from Sigma-Aldrich (Steinheim, Ger-
many) and Merck (Darmstadt, Germany), respectively. N-(2-Hydroxyethyl)
piperazine-N0-(2-ethanesulfonic acid) sodium salt (Na-HEPES), and cal-
cium chloride (CaCl2) were purchased from Sigma-Aldrich. Water was
purified and deionized by a multicartridge system (Sartorius, Goettingen,
Germany) and had a resistivity >18 MUm at 25C. Lipids were dissolved
in chloroform/methanol solution (1:1, v/v). All chemicals were used
as received: trimethoxymethylsilane, diethoxydimethylsilane, (p-chloro-
methyl)phenyltrimethoxysilane, (ABCR, Germany), dodecylbenzenesul-
fonic acid, chloroform (Sigma-Aldrich).Sample preparation
Poly(organosiloxane) NPs were synthesized by condensation of di- and tri-
alkoxysilanes as described previously (31–33). Briefly, the synthesis of
12 nm core-shell NPs (R ¼ 6.2 5 1.3 nm (TEM)) was carried out under
alkaline conditions using benzethonium chloride as surfactant at a fleet ratio
of 0.3. The core was fluorescently labeled by addition of rhodamine
B-(p-trimethoxysilyl)benzylester to the monomer mixture. 136 nm NPs
(R ¼ 68 5 13.5 nm (TEM)) were prepared with dodecylbenzenesulfonic
acid as surfactant (fleet ratio 0.001) by sequential condensation of polydi-
methylsiloxane-core and two shells; the inner shell was labeled by rhoda-
mine B during polycondensation.
The characterization of particle size in aqueous solution was carried out
by multiangle dynamic light scattering (DLS) using an ALV/CGS-3
Compact Goniometer System, with HeNe Laser (l0¼ 633 nm). All samples
were filtered (Millex-LCR filter, 0.45 mm pore size, Millipore) before
measurement. For determination of hydrodynamic radii, the autocorrelation
data were evaluated by applying a biexponential fit, m2 values were derived
from a cumulant fit at 90 (34). DLS measurements showed a hydrody-
namic radius Rh of 7.9 nm (m2 ¼ 0.11) for 12 nm particles and Rh of
70.9 nm (m2 ¼ 0.05) for 136 nm particles in aqueous dispersion.
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groups on the nanoparticle’s surface were endcapped with trimethylethox-
ysilane. The particles were washed or dialyzed in methanol to remove the
surfactant. By this procedure the surface properties of the NPs were
changed to hydrophobic and the particles were redispersed in chloroform
and visualized by TEM (33). The hydrodynamic radii of the hydrophobic
particles were determined by DLS in tetrahydrofuran. The resulting values
are Rh¼ 110 nm (m2 (90)¼ 0.06) for the big particles and Rh¼ 9.1 nm (m2
(90) ¼ 0.07) for the small particles.
The NPs were dissolved in chloroform to obtain 3.784  1012 NPs/mL
(5.98 mg/mL) of 136 nm NPs stock solution and 1.430  1016 NPs/mL
(17.13 mg/mL) of 12 nm NPs stock solution. The NPs were mixed in lipid
solutions (1 mg/mL) in concentrations of 1, 10, 20, 50, 100, and
1000 mg/mL for both 136 nm and 12 nm NPs to acquire physiological
relevance and hence the number of NPs in the case of 136 nm NPs is 103
times smaller than that of 12 nm NPs. The lipid-nanoparticle mixture, dis-
solved in chloroform/methanol (1:1, v/v) solution, was sonicated and in-
jected onto the subphase.Surface pressure-Area isotherms
All the film balance experiments were performed on an analytical Wilhelmy
film balance (Riegler and Kirstein, Mainz, Germany) with an operational
area of 144 cm2. All surface pressure measurements were done on
25 mM HEPES with 3 mM CaCl2 at pH 7.0 as buffered subphase at
20C. The sample solutions consisting of lipid mixtures and NPs was
injected onto the subphase and was left for an equilibration time of
10–15 min for the solvent to evaporate after which the lipid monolayer
formed was compressed at the rate of 2.9 cm2/min using a Teflon barrier.
The monolayer isothermal compressibility of the DPPC film was calcu-
lated using
Cs ¼ ð1=AÞðdA=dpÞ;
where Cs is the compressibility coefficient, A is the molecular area at a
given surface pressure, and p is the corresponding surface pressure. The
compressibility coefficient is known to indicate the lateral stiffness of the
monolayer at a given surface pressure.Video-enhanced epifluorescence microscopy
Domain structures of DPPC in the presence of NPs were observed by
doping the lipid solution with 0.5 mol% BODIPY-PC and visualizing by
means of an epifluorescence microscope (Olympus STM5-MJS,Olympus,
Hamburg, Germany) equipped with xy-stage and connected to a charge-
coupled device camera (Hamamatsu, Herrsching, Germany). The images
were captured at desired surface pressures by stopping the barrier. All the
measurements were done in pure water as the subphase at 20C.Langmuir-Blodgett transfer
The lipid mixtures with and without NPs were spread onto the 25 mM
HEPES with 3 mM CaCl2 at pH 7.0 subphase in a film balance (Riegler
and Kirstein) with an operational area of 39 cm2 and the monolayer
obtained was compressed with a velocity of 1.5 cm2/min to achieve the
desired surface pressure and area per molecule. The lipid film was allowed
to stabilize at the attained surface pressure and area per molecule for around
10 min and then an already positioned vertically dipped freshly cleaved
mica sheet is drawn upward with the speed of 0.7 mm/min. For the lipid
film with 12 nm NPs, this transfer is carried out at around 52.2 mN/m,
i.e., at the plateau region where multilayer protrusion structures are
observed. For the lipid mixture with 136 nm NPs, the film is transferred
at the beginning of the plateau and at the end of the plateau where the sur-face pressure is around 50.5 mN/m in either case. The area per molecule
value is attained by slowly stopping the barrier at the desired position
and stabilizing the lipid film for around 10 min before beginning the trans-
fer. All the transfers were done at 20C.AFM
The Lipid films transferred onto the mica sheet were scanned using
NanoWizard III (JPK Instruments, Berlin, Germany). Silicon nitride tips
(Budget Sensors, Sofia, Bulgaria) with a spring constant of 40 N/m and a
resonance frequency of 300 5 100 kHz were used. All the scanning was
performed in the intermittent contact mode in air at 20C. The images
were obtained at 512  512 pixel resolution and processed using JPK
data processing software.Vesicle insertion kinetic studies
Vesicle preparation
A phospholipid mixture containing DPPC/DPPG in the molar ratio 4:1 were
dissolved in a chloroform/methanol (1:1, v/v) solution and dried under a
stream of nitrogen at 50C. Traces of solvent were removed for at least
3 h at 50C in a vacuum oven. The dried lipid films were then hydrated
by adding a buffer containing 25 mM Hepes and 0.1 mM EDTA. The
suspension was kept for 30 min at 50C water bath and vortexed every
10 min. The resulting multilamellar vesicles solution was extruded from
a 100 nm pore size polycarbonate membrane to obtain a 100 nm large uni-
lamellar vesicle solution.
Vesicle insertion studies
The insertion experiments were performed using model LS monolayer on
25 mM Hepes and 3 mM CaCl2 at pH 7.0 as buffer subphase at 20
C.
The lipid film with and without NPs was spread at the air-water interface
on a film balance (Riegler and Kirstein) with an operational area of
39 cm2 and the monolayer obtained was compressed with a velocity of
1.5 cm2/min to achieve the desired surface pressure (25 mN/m in this
case). The lipid film was stabilized for at least 10 min before injecting
the large unilamellar vesicle (LUV) solution into the subphase. The in-
crease in surface pressure is measured with respect to time and the isotherm
obtained is used for analyzing the insertion kinetics of the model LS film in
the presence of different sized NPs.RESULTS
Size-dependent effect of NPs on surface activity
of DPPC monolayer
The size-dependent effect of hydrophobic NPs on the
surface activity of DPPC monolayers was studied using
the Langmuir film balance. DPPC forms the major com-
ponent of the model LS film and hence alteration in its phase
behavior consequently causes alteration in the phase
behavior of model LS films. The isotherm of a pure DPPC
monolayer consists of an initial gaseous phase succeeded
by a liquid-expanded phase (LE), a liquid-condensed (LC)
phase, and a solid phase. The phase transition from the LE
phase to the LC phase is intermediated by the LE-LC phase
coexistence region, which is signified by a plateau at a
surface pressure of around 5 mN/m. The isotherms illus-
trating the size-dependent effect of NPs on DPPC mono-
layer are presented in Fig. 1. In the presence of 12 nmBiophysical Journal 106(1) 289–298
FIGURE 1 Surface pressure-Area per lipid mole-
cule isotherm for (a) DPPC þ 12 nm NPs and (b)
DPPC þ 136 nm NPs with 25 mM Hepes þ
3 mM CaCl2 as the subphase. To see this figure in
color, go online.
292 Dwivedi et al.NPs no change in the isotherm occurred up to the measured
concentrations (Fig. 1 a). However, in the presence of
136 nm NPs, the isotherm is expanded toward a higher
area per molecule values diminishing the LE-LC coexis-
tence region (Fig. 1 b).
The compressibility values (Cs) (Table 1) are calculated
for the DPPC films in the LC phase at the area per molecule
value of 45 A˚2. With increasing concentration of the
136 nm NPs the compressibility values increased for the
DPPC monolayer.Size-dependent effect of NPs on line tension and
domain morphology of DPPC monolayer
A lipid monolayer forms phase separated domains on
compression depending on the surface pressure. The domain
morphology can be studied using epifluorescence micro-
scopy by doping the lipid monolayer with BODIPY-PC
dye, which is known to preferentially partition into the LE
phase. Hence, the LC phase appears as dark domains.
The size-dependent effect of NPs on the domains formed
by DPPC films is presented in Fig. 2. Increasing concentra-
tions of 12 nm NPs cause disruption of the domain
morphology beginning with formation of outgrowths at
the periphery of the LC domains at low concentrations of
the NPs (Fig. 2 a). The fluorescent NPs are visible at high
surface pressure values as bright stretches (shown in red)
against the compressed lipid monolayer background
because of the fluorescent Rhodamine B core of the
nanoparticles.
With increasing concentrations of 136 nm NPs the LC
domains form branched structures, which at high surface
pressure forms a mesh-like network (Fig. 2 b). The signifi-
cant decrease in the line tension between phases responsible
for domain morphology is noticeable along with profuse
disruption of the domain structures. The effect is consider-
ably strong even at a very low concentration of 1 mg/mL,TABLE 1 Compressibility values for DPPC film at the area per mol
CaCl2 buffer subphase in the presence of varying concentrations of
w/o NPs 10 mg/mL NPs
Cs(m/mN) 3.92  103 4.0  103
Biophysical Journal 106(1) 289–298which amounts to a much lower number of NPs (106 lipid
molecules per nanoparticle) as compared to that of 12 nm
NPs (102 lipid molecules per nanoparticle) (Fig. S2 in the
Supporting Material).
Hence, the presence of 136 nm NPs significantly alters
the phase behavior of DPPC monolayers and decreases
phase separation. To further understand the size-dependent
effect of NPs on model LS films, a DPPC/DPPG/SP-C
(80:20:0.4 mol%) mixture was used.Size-dependent effect of NPs on surface activity
of LS model system
The characteristic surface pressure-area isotherm for a pure
DPPC/DPPG/SP-C (80:20:0.4 mol %) lipid mixture shows a
continuous increase in the surface pressure upon compres-
sion until it reaches the surface pressure value of around
52 mN/m. There it forms a plateau signifying a squeeze
out of some of the lipid component of the monolayer, thus
preventing an increase in the surface pressure values for
around 5–10 A˚2 area per molecule region. This is explained
by the selective squeeze out of the fluid component of the
lipid monolayer forming multilayer stacks held together
by surfactant-specific proteins (SP-C in this case).
The size-dependent effect of NPs on the surface proper-
ties of the LS model system is illustrated in Fig. 3. The pres-
ence of 12 nm NPs in the LS model system monolayer does
not cause any significant change in the surface pressure-area
isotherm except at a very high concentration where the
plateau formation is inhibited (Fig. 3 a).
With increasing concentration of 136 nm NPs, however,
the plateau region of the LS film isotherms is enhanced
unlike for 12 nm NPs (Fig. 3 b). At the highest concentration
of 136 nm NPs that we measured (i.e., 100 mg/mL), the
compressibility of the lipid film at the plateau region is
increased immensely to achieve very low area per molecule
values on continuous compression. In addition, we observedecule value of 45.1 A˚2 in LC region on 25 mM HEPESD 3 mM
136 nm NPs at 20C.
25 mg/mL NPs 50 mg/mL NPs 100 mg/mL NPs
4.45  103 6.0  103 7.08  103
FIGURE 2 Epifluorescence microscopy images for
DPPC in the presence of increasing concentration of
(a) 12 nmNPs and (b) 136 nm NPs on water as the sub-
phase at 20C. The DPPC monolayer is doped with
0.5 mol% BODIPY-PC, which preferentially partitions
into the LE phase. The images are taken at 10 mN/m
surface pressure. Scale bar is 50 mm. To see this figure
in color, go online.
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molecule values with increasing nanoparticle concentration.
From the repetitive cyclic compression expansion cycles for
the model LS system in the presence of 12 nm as well as
136 nm NPs, we observed no variation in the hysteresis
effect suggesting that there is no loss of material from the
lipid monolayer into the subphase in either case (Fig. S3).
This also implies the retention of NPs in the lipid monolayer
after three compression and expansion cycles for both 12 nm
as well as 136 nm NPs.Surface activity studies of bare NPs
To study the surface activity of bare NPs, the nanoparticle
solutions were spread onto the buffered subphase and com-
pressed to achieve very low area per nanoparticle values as
technically feasible. Using film balance, often, molecular
arrangements can be contemplated based on the surface
activity of the molecules (or particles) of interest. Higher
surface activity for a wide range of area per nanoparticle im-
plies a higher level of interaction between the molecules and
hence lesser affinity between the NPs and the aqueous sub-
phase. This consequently gives an idea of the hydrophobic-
ity of the nanoparticle and hence the high free energy barrier
encountered by the NPs to enter into the subphase.As shown in Fig. S4 the wide range of area per molecule
values for 136 nm NPs reveal the high surface activity of
these particles, which can be compressed to very low area
per nanoparticle values without collapsing into the sub-
phase. The 12 nm NPs, on the other hand, show compara-
tively less surface activity properties and display a sudden
increase in surface pressure and a sudden collapse on
compression. The wider range of surface activity can be
explained by the very high free energy barrier encountered
by the 136 nm hydrophobic NPs at the aqueous interface
to enter into the aqueous subphase. The free energy barrier
is also encountered by the 12 nm NPs; however, the free en-
ergy barrier experienced by the 136 nm NPs is much larger
inhibiting the collapse of the NPs into the subphase.Size-dependent effect of NPs on multilayer
protrusion structures
To study the surface topology of the LS model system at the
plateau region in the presence of both 12 and 136 nm NPs
the AFM technique was used. The lipid film was transferred
at the plateau region of the isotherm from the aqueous
surface onto a solid substrate and scanned under AFM. To
study the surface topology of the model LS film in the
presence of 136 nm NPs at the enhanced plateau region,FIGURE 3 (a) Pressure-Area isotherm for
DPPC/DPPG/SP-C (80:20:0.4 mol%) þ 12 nm
NPs. (b) Pressure-Area isotherm for DPPC/
DPPG/SP-C (80:20:0.4 mol%) þ 136 nm NPs.
All measurements were done on 25 mM Hepes þ
3 mM CaCl2 as the subphase at 20
C. To see this
figure in color, go online.
Biophysical Journal 106(1) 289–298
294 Dwivedi et al.the lipid film was transferred at both the initial plateau re-
gion and at the end plateau region.
The AFM scan for pure DPPC/DPPG/SP-C
(80:20:0.4 mol%) monolayer lipid film at the plateau region
shows network structures that are multilayer protrusions as
previously observed (22).
Surface topology analysis of LS model system in the pres-
ence of 12 nm NPs
The protrusion structures are not affected noticeably by the
presence of 12 nm NPs, in the applied concentration
(Fig. 4 b). They are visibly localized around the protrusion
structures (marked by arrows). High-resolution scanning
confirms the presence of NPs associated with the protrusion
structures (see Fig. 5 a).
Surface topology analysis of LS model system in the pres-
ence of 136 nm NPs
AFM scans for the LS model system in the presence of
136 nm NPs reveal a significant lateral disruption of theFIGURE 4 AFM topography images of (a) pure DPPC/DPPG/SP-C (80:20:0
region; (c) with 100 mg/mL 136 nm NPs transferred at initial plateau region; (d) w
on 25 mM Hepes þ 3 mM CaCl2 as the subphase at 20C. The clusters of NPs a
see this figure in color, go online.
Biophysical Journal 106(1) 289–298network structures (Fig. 4, c and d). At the initial plateau
region, the network structures consisting of multilayer pro-
trusions are intact (Fig. 4 c). However, at the end plateau
region, the network structures are considerably disrupted
forming laterally disordered profuse multilayer protrusions
(Fig. 4 d). With increasing concentration of NPs the lateral
disorder increases significantly as shown in Fig. S6. The
highest clusters with a height of around 100 nm (marked
by arrows) were imaged under high resolution. These
images clearly show the presence of 136 nm NPs associated
with the protrusion structures (Fig. 5 b). The topography
images are supplemented by phase images that have higher
clarity revealing a cluster of NPs (Fig. 5 c). It should be
noted that the size measured for these NPs are in aqueous
dispersions. However, the 136 nm NPs present on the
mica substrate within the LS model system film are dried
rendering the size to be around 100 nm because of the elastic
properties manifested by the 136 nm NPs.
The 136 nm NPs visible in the phase images are similar to
those obtained in TEM micrograph images (Fig. S7). The.4 mol%) monolayer lipid film; (b) with 100 mg/mL 12 nm NPs at plateau
ith 100 mg/mL 136 nm NPs at end plateau region. The film was compressed
round the protrusion structures are marked by arrows. Scale bar is 5 mm. To
FIGURE 5 High-resolution imaging for DPPC/DPPG/SP-C (80:20:0.4
mol%) monolayer lipid films. (a) 3D topography image with 12 nm NPs;
(b) 3D topography image with 136 nm NPs; (c) Phase images showing
136 nm NPs with higher clarity; (d) Height profile analysis for 136 nm
NPs clusters. To see this figure in color, go online.
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deformation during packing (Fig. 5 c, Fig. S7 b). Hence, the
negative phase change at the top of the 136 nm NPs could be
explained by the ability of the cantilever to press into the
nanoparticle during measurement. The height profile of
the nanoparticle cluster shows height up to 100 nm with
curved edges corresponding to the shape of the nanoparticle.
As shown by the hysteresis studies, the continuous
compression of the LS model system film in the presence
of 136 nm NPs does not show any irreversible damage to
the model surfactant film due to a loss of any component
into the subphase (Fig. S3). This is consistent with the
AFM studies, which show the formation of multilayer steps
with step heights of 5 nm, i.e., for a bilayer (Fig. 6, marked
by arrows) around the NPs. Hence, in the presence ofFIGURE 6 AFM images of for DPPC/DPPG/SP-C (80:20:0.4 mol%) mono
(marked by arrows). The AFM image is accompanied by its height profiles to t136 nm NPs, the structures formed are indeed multilayer
protrusion structures and not collapse structures due to a
disruption of the film.Effect of nanoparticle size on vesicle insertion
kinetics of model LS films
The natural LS monolayer is constantly recycled and replen-
ished with new lipid material from the subphase by the
vesicle insertion process. This process is essential for main-
taining the integrity and functional activity of the lung sur-
factant monolayer (32). We have tried to mimic this process
by inserting DPPC/DPPG (4:1) LUVs into the subphase
containing model LS film at the air-water interface. The
model LS monolayer is compressed up to 25 mN/m, stabi-
lized for 10 min, and the LUVs are inserted into the sub-
phase. The increase in surface pressure is monitored with
time to obtain an isotherm, which gives information about
the insertion kinetics of the vesicles into the monolayer.
Fig. 7 illustrates the effect of different sized NPs on the
vesicle insertion kinetics of model LS monolayer. The pres-
ence of higher numbers of 12 nm NPs does not cause a sig-
nificant effect on the vesicle insertion process of this model
LS film. However, in the presence of a comparatively lower
number of 136 nm NPs, the vesicle insertion process is
considerably inhibited.DISCUSSION
Previously, we studied the effect of hydrophobic NPs
(AmorSil20) with a diameter of 20 nm and showed that
these NPs are localized around the multilayer protrusion
structures. The NPs with 20 nm diameter did not cause
any significant damage to the lung surfactant surface activ-
ity except at a very high concentration of 1000 mg/mL
wherein the plateau formation was inhibited. The multilayer
protrusion structures consequently were also unaffected bylayer lipid films with 136 nm NPs showing presence of multilayer steps
he right. To see this figure in color, go online.
Biophysical Journal 106(1) 289–298
FIGURE 7 Vesicle insertion kinetic studies for DPPC/DPPG/SP-C
(0.4 mol%) monolayer with different numbers of 12 nm and 136 nm
NPs. The DPPC/DPPG (4:1) vesicles were inserted at 25 mN/m surface
pressure. All measurements were done on 25 mM Hepes and 3 mM
CaCl2 as subphase at 20
C. To see this figure in color, go online.
296 Dwivedi et al.the presence of these hydrophobic NPs. Furthermore, the
NPs were confirmed to retain in the model LS film after
continuous compression expansion cycles. In this study,
we report that this effect of hydrophobic NPs is size depen-
dent and that the effect of 136 nm NPs is much more struc-
ture damaging.
The surface activity of model LS films remained unaf-
fected in the presence of 12 nm NPs, except at very high
concentrations similar to the 20 nm NPs. However, with
the increasing concentration of 136 nm NPs, the plateau
region was considerably enhanced, rendering the surfactant
film incapable of increasing the surface pressure to the
desired value, thus causing potential lung surfactant
dysfunction.
The AFM scans of the model LS films at the plateau
region in the presence of 12 nm NPs displayed results
similar to those obtained with 20 nm NPs. The 12 nm hydro-
phobic NPs are localized around the protrusion structures,
also evidenced by the high-resolution images. The network
structures consisting of multilayer protrusions are unaltered
in the presence of both 12 and 20 nm hydrophobic NPs. For
136 nm NPs the lipid film was transferred at two different
regions of the plateau to examine the surface topography
of multilayer protrusion structures at different compressed
states. The AFM scans for initial plateau regions show no
significant change in the network structures. However, at
the end plateau region, the network structures are laterally
disrupted forming profuse multilayer protrusion structures.
The 136 nm NPs can be spotted as clusters associated
with the protrusion structures, also confirmed by the high-
resolution images. Furthermore, we show that the profuse
structures present are indeed multilayers formed due to
continuous compression and not random collapse structures.
These enhanced multilayered protrusion structures can be
well correlated with the enhanced plateau region in theBiophysical Journal 106(1) 289–298isotherm of the model LS film in the presence of 136 nm
NPs. The multilayer protrusion formation is explained by
selective squeeze out of the fluid component of the film.
Enhanced multilayer protrusion formation implies an
increased amount of lipid molecules in the fluid component
of the film. In addition, lateral disruption of the network
structures implies increased mixing of rigid and fluid
domains, i.e., decreased phase separation. Furthermore,
the LS model film does not exhibit any variation in the
hysteresis of the isotherm in the presence of any of the
NPs with respect to multiple compression reexpansion
cycles. Hence, the NPs are retained in the surfactant film
possibly due to their highly hydrophobic surface and conse-
quently high free energy barrier to enter into the subphase.
The isotherms for bare NPs illustrate high surface activity
of the 136 nm NPs suggesting a high-energy barrier encoun-
tered by the 136 nm hydrophobic NPs for penetrating into
the aqueous subphase. This phenomenon also partially ex-
plains the noncollapse behavior of the LS model system in
the presence of the 136 nm NPs even after continuous
compression. The hydrophobic NPs interact with the hydro-
phobic acyl chains of the lipid molecules and retain the lipid
molecules along with it preventing collapse. We expect a
similar interaction in the case of 12 nm NPs; however, it
is not prominently visible in these data sets.
Because DPPC forms the major component of the model
LS film, any alteration in its phase behavior due to the pres-
ence of differently sized NPs can be extrapolated to the
model LS film. Hence, the size-dependent effect of NPs
on phase behavior and domain morphology of DPPC mono-
layers was studied. The isotherm of a DPPC monolayer did
not display any appreciable change in the presence of 12 nm
NPs. However, in the presence of 136 nm NPs, the LE-LC
coexistence region was diminished. To emphasize the effect
of 136 nm NPs on the isotherms of the DPPC monolayer, we
have calculated the compressibility values at the LC phase
region. With increasing concentration of 136 nm NPs the
compressibility values increase, which imply decreased
cooperativity between lipid molecules. Hence, 136 nm
NPs interfere with the lipid packing order and decrease
intermolecular interactions. This can also be true for
12 nm NPs but the isotherms data alone for 12 nm NPs
are not conclusive.
The epifluorescence microscopy images reveal slightly
disrupted domain morphology for DPPC monolayers in
the presence of 12 nm NPs. Furthermore, due to the pres-
ence of the high numbers of these fluorescent 12 nm NPs,
they are clearly visible at high surface pressure. In the pres-
ence of 136 nm NPs, however, the domain morphology is
tremendously disrupted causing branching of the domains
at low surface pressure and formation of mesh-like network
structures at high surface pressure. The disruption in the
domain morphology implies probably localization of the
NPs at the phase boundaries and decreased line tension
suggests decreased phase separation. This is in accordance
Size Influences Effect of Hydrophobic NPs on LS Model System 297with the AFM scans of DPPC/DPPG/SP-C mixtures where
DPPC is the major component. The lateral disruption of
the network structures in the AFM scans of DPPC/DPPG/
SP-C mixture are rationalized because of increased mixing
of rigid and fluid domains, i.e., decreased phase separation.
Hence, in the presence of 136 nm NPs, line tension between
different phases is reduced largely causing mixing of do-
mains in the lipid film, which is responsible for lateral
disruption of the network structures. This increase in the
fluid component causes enhanced multilayer protrusion
formation consequently causing potential lung surfactant
dysfunction.
A 136 nm nanoparticle should occupy around 17,000 nm2
area on the aqueous subphase, whereas the area occupied by
the lipid molecule is 0.6 nm2, which is almost 106 times
smaller than that of the nanoparticle. Considering that the
number of lipid molecules is 105 per nanoparticle, the total
area occupied by the 136 nm NPs should be almost of the
same order as the total area occupied by the lipid molecules.
Given this fact, the whole isotherm of a DPPC monolayer
should be shifted toward higher area per molecule values
(as opposed to expansion of LE phase region alone) to
account for the area occupied by the 136 nm nanoparticle.
However, this is not the case even at the highest concentra-
tion of the 136 nm NPs. This suggests that the lipid mole-
cules are displaced from the air-water interface to the
surface of the nanoparticle attributable to hydrophobic inter-
action between the acyl chains and the hydrophobic nano-
particle surface. Thus, it renders fewer lipid molecules on
the aqueous subphase leaving the total area occupied essen-
tially the same. In addition, it should be noticed that the
transition pressure is unaltered in the presence of NPs indi-
cating that there might be a possible phase separation be-
tween the lipid bound to the nanoparticles and the free
lipid molecules.
The presence of 136 nm NPs also has a significant effect
on the vesicle insertion process as seen from the vesicle
insertion kinetics studies. The vesicle insertion process is
thought to be a two-step mechanism—initial Caþ2-mediated
adsorption of the vesicles onto the model LS monolayer,
rupture of the vesicles, and reincorporation of the lipids
from the vesicles into the monolayer facilitated by surfac-
tant proteins. As seen in Fig. 7, the presence of higher
numbers of 12 nm NPs has a negligible effect on the inser-
tion kinetics of the model LS film. At very high concentra-
tions, the inhibition effect of these NPs is much more
prominent (data not shown) where the half-time increases
with increasing concentration. These results are similar to
those observed with the 20 nm diameter NPs. In the
presence of 136 nm NPs the inhibitory effect is visibly
prominent even at comparatively lower numbers of NPs.
Another important observation is that the shape of the curve
is hyperbolic in the presence of 12 nm NPs and sigmoidal in
the presence of 136 nm NPs. The inhibitory effect of the
12 nm NPs can be explained by a direct or indirect inter-action of the NPs with the surfactant protein-C, thus inhib-
iting its function in vesicle insertion. This is also
emphasized by the fact that the isotherm of model LS mono-
layers show inhibited plateau regions in the presence of very
high concentrations of 12 nm NPs. As previously discussed,
these NPs are known to be found associated with the protru-
sion structures and hence with the fluid component of the
film. The surfactant-specific proteins are also known to be
present in the DPPG-enriched fluid component of the film.
This increases the possibility of an interaction between the
surfactant protein-C and the 12 nm nanoparticle, which is
observable only at very high concentrations of the NPs.
The effect of 136 nm nanoparticles on the vesicle insertion
curve however is significantly different and cannot be sim-
ply explained with the previous theory of nanoparticle-
protein interaction. From the previous discussion, we
deduced a possible interaction of the fluid component of
the model LS film with the nanoparticles. The fluid com-
ponent is mainly enriched in DPPG. DPPG being negatively
charged is also involved in the adsorption of the vesicles,
mediated by Caþ2 ions, and plays an important role in the
electrostatic interaction between the lipid monolayer and
the LUVs in the subphase (33,34). In the presence of
136 nm NPs, DPPG molecules may possibly form a lipid
layer on the nanoparticle and hence the number of DPPG
molecules available for adsorption of LUVs would decrease
leading to an initial lag phase in the insertion curve. With the
eventual adsorption and reincorporation of the new lipid
material from the subphase to the monolayer, the number
of DPPG molecules in the monolayer increases subse-
quently leading to an increased adsorption of the vesicles.
This process is similar to a cooperative process and hence
would result in a sigmoidal curve as obtained in Fig. 7.
Due to its size, 136 nm NPs have much more area to occupy
larger amounts of lipid molecules than the 12 nm NPs.
Hence, even a small number of 136 nm NPs has a consider-
ably higher inhibitory effect on the insertion kinetics than
the 12 nm NPs.CONCLUSION
This study shows the effect of different sized NPs on model
LS films and proves that the size of the NPs is an important
factor responsible for causing severe structural and func-
tional damage to the model LS films. The surface activity
of the model LS film is almost unaffected in the presence
of 12 nm NPs, which is similar to the results obtained for
20 nm NPs. However, in the presence of 136 nm NPs the
plateau region is enhanced significantly rendering the model
LS film highly compressible. The AFM scans reveal forma-
tion of profuse multilayer protrusion structures responsible
for the enhanced plateau region. The fluorescence micro-
scopy images for DPPC monolayers in the presence of
136 nm NPs show a decreased tendency for a phase separa-
tion due to reduction in the line tension. This is inBiophysical Journal 106(1) 289–298
298 Dwivedi et al.accordance with the AFM studies where the network struc-
ture of model LS film is disrupted in the presence of 136 nm
NPs implying diffusive mixing of rigid and fluid domains.
The vesicle insertion kinetics is inhibited in the presence
of fewer numbers of 136 nm NPs as compared with the
12 nm NPs where the effect is negligible. The mechanism
for the inhibitory effect is also discussed in the study based
on the size of the NPs. It is worth noticing that fewer
numbers of 136 nm NPs have much more structural and
functional damaging effect than the comparatively higher
number of 12 nm NPs.SUPPORTING MATERIAL
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